Proton pump inhibitors (PPIs) were initially introduced in the 1980s. Since then PPIs are one of the most common medications prescribed throughout the United States with indications for use in peptic ulcer disease, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and H. pylori infections. The latest research on the long-term risks of PPI treatment has both...